| Intimation of One on One Investor Meets, June 2026 |
|
| Press Release Binimetinib Tablets, 45 mg |
|
| Appointment of Mr. Sujit Bhayani as a Non-Executive Independent Director |
|
| Press Release Tretinoin Cream USP, 0.05 |
|
| Intimation of Re-affirmation of Credit Rating CARE |
|
| Press Release Larotrectinib Capsules, 25 mg and 100 mg |
|
| Intimation Under Reg 30 Newspaper Publication For Opening Of Another Special Window For Transfer And Dematerialization Of Physical Securities |
|
| Intimation of Newspaper Publication of Advance Notice of AGM |
|
| Intimation of Execution of Shareholder Agreement |
|
| Specimen Letter To Physical Shareholder For Updating KYC Details |
|
| Press Release Haloperidol Tablets, USP |
|
| SE Intimation SMP, 3rd June, 2026 |
|
| SE Intimation SMP, 2nd June, 2026 |
|
| SE Intimation SMP, 1st June, 2026 |
|
| Intimation of Investor Meet, 29th May, 2026 |
|
| Press Release Levothyroxine Sodium Tablets USP |
|
| Alembic Pharmaceuticals Limited passes ANVISA (Brazil) GMP Inspection for its API-III Facility at Karakhadi |
|
| Intimation under Regulation 30 Newspaper Publication of Audited Financial Results for the quarter ended 31st March 2026 |
|
| SE Intimation SMP, 14th May, 2026 |
|
| Alembic Pharmaceuticals Limited receives EIR for its Injectable Facility (F-III), Karakhadi |
|
| Press Release Darolutamide Tablets, 300 mg |
|
| Intimation Under Reg 30 Newspaper Publication |
|
| SE Intimation SMP, 4th May, 2026 |
|
| Specimen Reminder Letter to Shareholders IEPF |
|
| SE Intimation SMP, 1st May, 2026 |
|
| Intimation of Investor Meet, 15th May, 2026 |
|
| SE Intimation SMP, 27th April, 2026 |
|
| Intimation of BM 15th May, 2026 |
|
| Press Release Fingolimod Capsules, 0.5 mg |
|
| Intimation of Incorporation of Wholly-Owned Subsidiary |
|
| Intimation of Incorporation of Subsidiary |
|
| Intimation Under Regulation 30 Newspaper Publication Of Saksham Niveshak-Second 100-Day Campaign |
|
| Press Release Methotrexate Injection USP |
|
| Intimation Under Reg 30 Newspaper Publication For Opening Of Another Special Window For Transfer And Dematerialization Of Physical Securities |
|
| Press Release Dapagliflozin Tablets, 5 mg and 10 mg |
|
| Relinquishment of Mr. Chirayu Amin as CEO of the Company |
|
| Reappointment of Mr. Pranav Amin as Managing Director of the Company |
|
| Appointment of Mr. Rajkumar Baheti as Non Executive Non Independent Director of the Company |
|
| Appointment of Mr. Chirayu Amin as Executive Chairman of the Company |
|